Molecular mechanisms for lipopolysaccharide-induced biphasic activation of nuclear factor-kappa B (NF-kappa B). (Q40703735)

22 September 2017

title

Molecular mechanisms for lipopolysaccharide-induced biphasic activation of nuclear factor-kappa B (NF-kappa B). (English)

1 reference

22 September 2017

0 references

0 references

Su-Ji Han

1

1 reference

22 September 2017

Hyun-Mi Ko

2

1 reference

22 September 2017

Jung-Hwa Choi

3

1 reference

22 September 2017

Kook Heon Seo

4

1 reference

22 September 2017

Hyun-Suk Lee

5

1 reference

22 September 2017

Eun-Kyoung Choi

6

1 reference

22 September 2017

Il-Whan Choi

7

1 reference

22 September 2017

Hern-Ku Lee

8

1 reference

22 September 2017

Suhn-Young Im

9

1 reference

22 September 2017

language of work or name

English

0 references

publication date

13 September 2002

1 reference

Journal of Biological Chemistry

22 September 2017

published in

1 reference

22 September 2017

volume

277

1 reference

22 September 2017

issue

47

1 reference

22 September 2017

page(s)

44715-44721

1 reference

Multiple nuclear factors interact with the immunoglobulin enhancer sequences

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1074/JBC.M202524200

Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-kappa B transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M202524200

Listeria monocytogenes infection of P388D 1 macrophages results in a biphasic NF-κB (RelA/p50) activation induced by lipoteichoic acid and bacterial phospholipases and mediated by IκBα and IκBβ degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M202524200

Involvement of nuclear factor‐xB in platelet‐activating factor‐mediated tumor necrosis factor‐α expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M202524200

Platelet-activating factor-induced early activation of NF-kappa B plays a crucial role for organ clearance of Candida albicans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M202524200

Selective involvement of reactive oxygen intermediates in platelet-activating factor-mediated activation of NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M202524200

Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M202524200

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M202524200

Tumor necrosis factor alpha-induced angiogenesis depends on in situ platelet-activating factor biosynthesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M202524200

Activation of NF-kappa B and immunoglobulin expression in response to platelet-activating factor in a human B cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M202524200

Platelet-activating factor induces NF-kappa B activation through a G protein-coupled pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M202524200

Dual role of protein kinase C in the regulation of cPLA2-mediated arachidonic acid release by P2U receptors in MDCK-D1 cells: involvement of MAP kinase-dependent and -independent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M202524200

The Toll/interleukin-1 receptor domain: a molecular switch for inflammation and host defence

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M202524200

The evolution and genetics of innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M202524200

MyD88: An Adapter That Recruits IRAK to the IL-1 Receptor Complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M202524200

TRAF6 is a signal transducer for interleukin-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M202524200

TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M202524200

IRAK: a kinase associated with the interleukin-1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M202524200

IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M202524200

Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M202524200

NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M202524200

Tumour necrosis factors receptor associated signalling molecules and their role in activation of apoptosis, JNK and NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M202524200

Alymphoplasia is caused by a point mutation in the mouse gene encoding Nf-kappa b-inducing kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M202524200

Defective lymphotoxin-beta receptor-induced NF-kappaB transcriptional activity in NIK-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M202524200

Cytoplasmic phospholipase A2 activity and gene expression are stimulated by tumor necrosis factor: dexamethasone blocks the induced synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M202524200

Cell-specific regulation of type II phospholipase A2 expression in rat mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M202524200

Phospholipase A2 inhibitors and leukotriene synthesis inhibitors block TNF-induced NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M202524200

Possible new role for NF-kappaB in the resolution of inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M202524200

A double-blind placebo-controlled study of an infusion of lexipafant (Platelet-activating factor receptor antagonist) in patients with severe sepsis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M202524200

21 January 2018

Identifiers

DOI

10.1074/JBC.M202524200

1 reference

22 September 2017

1 reference